Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Oct. 31, 2018
Jul. 31, 2018
Current assets    
Cash and cash equivalents $ 19,016,067 $ 3,803,627
Prepaid expenses and other current assets 2,150,966 1,643,749
Investment securities 9,458,814 23,174,447
Total Current Assets 30,625,847 28,621,823
Property and equipment, net 1,204,791 1,265,662
Other long-term assets 346,470 358,987
Total Assets 32,177,108 30,246,472
Current liabilities    
Accounts payable and accrued liabilities 4,169,797 4,778,892
Accrued compensation and related 1,487,579 1,070,744
Total Current Liabilities 5,657,376 5,849,636
Other long-term liabilities 1,322,011 1,472,630
Total Liabilities 6,979,387 7,322,266
Commitments and Contingencies (Note 8)
Stockholders' Equity    
Common stock authorized - 160,000,000 common shares with a par value of $0.0001, common stock issued and outstanding - 59,674,487 and 53,511,626 common shares as of October 31, 2018 and July 31, 2018, respectively 5,968 5,351
Additional paid-in capital 155,585,148 145,744,373
Warrants issued and outstanding - 8,928,905 and 8,958,059 warrants as of October 31, 2018 and July 31, 2018, respectively 11,171,165 11,271,327
Accumulated other comprehensive income (loss) 91,876 (16,024)
Accumulated deficit (141,656,436) (134,080,821)
Total Stockholders' Equity 25,197,721 22,924,206
Total Liabilities and Stockholders' Equity $ 32,177,108 $ 30,246,472